SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-21-006626
Filing Date
2021-02-04
Accepted
2021-02-03 21:41:03
Documents
13

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea134279-s1_aditxthera.htm S-1 1708752
2 OPINION OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP ea134279ex5-1_aditxthera.htm EX-5.1 13571
3 CONSENT OF DBBMCKENNON ea134279ex23-1_aditxthera.htm EX-23.1 2371
4 GRAPHIC image_001.jpg GRAPHIC 7724
5 GRAPHIC image_002.jpg GRAPHIC 52738
6 GRAPHIC image_003.jpg GRAPHIC 67669
7 GRAPHIC image_004.jpg GRAPHIC 56783
8 GRAPHIC image_005.jpg GRAPHIC 40287
9 GRAPHIC image_006.jpg GRAPHIC 33092
10 GRAPHIC image_007.jpg GRAPHIC 32657
11 GRAPHIC image_008.jpg GRAPHIC 81259
12 GRAPHIC image_009.jpg GRAPHIC 8502
13 GRAPHIC ex5-1_001.jpg GRAPHIC 9332
  Complete submission text file 0001213900-21-006626.txt   2264338
Mailing Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043
Business Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043 909-488-0844
Aditx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-252711 | Film No.: 21588597
SIC: 2834 Pharmaceutical Preparations